Cargando…
Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study
OBJECTIVE: To determine the value of [F-18]PBR06-PET for assessment of microglial activation in the cerebral gray matter in patients with MS. METHODS: Twelve patients with MS (7 relapsing-remitting and 5 secondary progressive [SP]) and 5 healthy controls (HCs) had standardized uptake value (SUV) PET...
Autores principales: | Singhal, Tarun, O'Connor, Kelsey, Dubey, Shipra, Pan, Hong, Chu, Renxin, Hurwitz, Shelley, Cicero, Steven, Tauhid, Shahamat, Silbersweig, David, Stern, Emily, Kijewski, Marie, DiCarli, Marcelo, Weiner, Howard L., Bakshi, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624145/ https://www.ncbi.nlm.nih.gov/pubmed/31355321 http://dx.doi.org/10.1212/NXI.0000000000000587 |
Ejemplares similares
-
Regional microglial activation in the substantia nigra is linked with
fatigue in MS
por: Singhal, Tarun, et al.
Publicado: (2020) -
Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability
por: Chu, Renxin, et al.
Publicado: (2017) -
The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis
por: Dupuy, Sheena L., et al.
Publicado: (2016) -
The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing‐Remitting Multiple Sclerosis
por: Singhal, Tarun, et al.
Publicado: (2016) -
Widespread Glial Activation in Primary Progressive Multiple Sclerosis Revealed by (18)F-PBR06 PET: A Clinically Feasible, Individualized Approach
por: Singhal, Tarun, et al.
Publicado: (2021)